107 related articles for article (PubMed ID: 34487729)
1. Human α-defensin 5 suppressed colon cancer growth by targeting PI3K pathway.
Qiao Q; Bai R; Song W; Gao H; Zhang M; Lu J; Hong M; Zhang X; Sun P; Zhang Q; Zhao P
Exp Cell Res; 2021 Oct; 407(2):112809. PubMed ID: 34487729
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effect of human DEFA5 in growth of gastric cancer by targeting BMI1.
Wu Z; Ding Z; Cheng B; Cui Z
Cancer Sci; 2021 Mar; 112(3):1075-1083. PubMed ID: 33503272
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of GNAS promotes breast cancer cell proliferation and migration via the PI3K/AKT/Snail1/E-cadherin axis.
Jin X; Zhu L; Cui Z; Tang J; Xie M; Ren G
Clin Transl Oncol; 2019 Sep; 21(9):1207-1219. PubMed ID: 30767161
[TBL] [Abstract][Full Text] [Related]
4. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway.
Li J; Ye D; Shen P; Liu X; Zhou P; Zhu G; Xu Y; Fu Y; Li X; Sun J; Xu J; Zhang Q
J Exp Clin Cancer Res; 2020 Oct; 39(1):212. PubMed ID: 33032635
[TBL] [Abstract][Full Text] [Related]
5. PTPN3 Inhibits the Growth and Metastasis of Clear Cell Renal Cell Carcinoma via Inhibition of PI3K/AKT Signaling.
Peng XS; Yang JP; Qiang YY; Sun R; Cao Y; Zheng LS; Peng LX; Lang YH; Mei Y; Li CZ; Meng DF; Liu ZJ; Wang MD; Zhou FJ; Huang BJ; Qian CN
Mol Cancer Res; 2020 Jun; 18(6):903-912. PubMed ID: 32169891
[TBL] [Abstract][Full Text] [Related]
6. Roles of DANCR/microRNA-518a-3p/MDMA ceRNA network in the growth and malignant behaviors of colon cancer cells.
Sun Y; Cao B; Zhou J
BMC Cancer; 2020 May; 20(1):434. PubMed ID: 32423468
[TBL] [Abstract][Full Text] [Related]
7. A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling.
Zheng X; Chen L; Zhou Y; Wang Q; Zheng Z; Xu B; Wu C; Zhou Q; Hu W; Wu C; Jiang J
Mol Cancer; 2019 Mar; 18(1):47. PubMed ID: 30925892
[TBL] [Abstract][Full Text] [Related]
8. STEAP2 is down-regulated in breast cancer tissue and suppresses PI3K/AKT signaling and breast cancer cell invasion in vitro and in vivo.
Yang Q; Ji G; Li J
Cancer Biol Ther; 2020; 21(3):278-291. PubMed ID: 31696760
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
10. Let‑7i‑5p inhibits the proliferation and metastasis of colon cancer cells by targeting kallikrein‑related peptidase 6.
Song J; Wang L; Ma Q; Yang Y; Yang Z; Wang B; He N
Oncol Rep; 2018 Sep; 40(3):1459-1466. PubMed ID: 30015976
[TBL] [Abstract][Full Text] [Related]
11. IDO1 and Kynurenine Pathway Metabolites Activate PI3K-Akt Signaling in the Neoplastic Colon Epithelium to Promote Cancer Cell Proliferation and Inhibit Apoptosis.
Bishnupuri KS; Alvarado DM; Khouri AN; Shabsovich M; Chen B; Dieckgraefe BK; Ciorba MA
Cancer Res; 2019 Mar; 79(6):1138-1150. PubMed ID: 30679179
[TBL] [Abstract][Full Text] [Related]
12. Anti-allergic drug azelastine suppresses colon tumorigenesis by directly targeting ARF1 to inhibit IQGAP1-ERK-Drp1-mediated mitochondrial fission.
Hu HF; Xu WW; Li YJ; He Y; Zhang WX; Liao L; Zhang QH; Han L; Yin XF; Zhao XX; Pan YL; Li B; He QY
Theranostics; 2021; 11(4):1828-1844. PubMed ID: 33408784
[TBL] [Abstract][Full Text] [Related]
13. Effect of rs67085638 in long non-coding RNA (CCAT1) on colon cancer chemoresistance to paclitaxel through modulating the microRNA-24-3p and FSCN1.
Xiao ZS; Zhao L; Zhang XN; Li HX; Yin ZH
J Cell Mol Med; 2021 Apr; 25(8):3744-3753. PubMed ID: 33709519
[TBL] [Abstract][Full Text] [Related]
14. A novel protein encoded by circFNDC3B inhibits tumor progression and EMT through regulating Snail in colon cancer.
Pan Z; Cai J; Lin J; Zhou H; Peng J; Liang J; Xia L; Yin Q; Zou B; Zheng J; Qiao L; Zhang L
Mol Cancer; 2020 Apr; 19(1):71. PubMed ID: 32241279
[TBL] [Abstract][Full Text] [Related]
15. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
[TBL] [Abstract][Full Text] [Related]
16. Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn's colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease.
Rana T; Korolkova OY; Rachakonda G; Williams AD; Hawkins AT; James SD; Sakwe AM; Hui N; Wang L; Yu C; Goodwin JS; Izban MG; Offodile RS; Washington MK; Ballard BR; Smoot DT; Shi XZ; Forbes DS; Shanker A; M'Koma AE
PLoS One; 2021; 16(3):e0246393. PubMed ID: 33690604
[TBL] [Abstract][Full Text] [Related]
17. LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway.
Lei Y; Wang YH; Wang XF; Bai J
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6315-6323. PubMed ID: 30338799
[TBL] [Abstract][Full Text] [Related]
18. Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy.
Li B; Xu WW; Lam AKY; Wang Y; Hu HF; Guan XY; Qin YR; Saremi N; Tsao SW; He QY; Cheung ALM
Oncotarget; 2017 Jun; 8(24):38755-38766. PubMed ID: 28418888
[TBL] [Abstract][Full Text] [Related]
19. TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K/AKT/mTOR-glycolysis signaling axis.
Li R; Weng L; Liu B; Zhu L; Zhang X; Tian G; Hu L; Li Q; Jiang S; Shang M
J Cell Biochem; 2020 Feb; 121(2):1986-1997. PubMed ID: 31693252
[TBL] [Abstract][Full Text] [Related]
20. miR-873-5p inhibits the progression of colon cancer via repression of tumor suppressor candidate 3/AKT signaling.
Zhu Y; Zhang X; Qi M; Zhang Y; Ding F
J Gastroenterol Hepatol; 2019 Dec; 34(12):2126-2134. PubMed ID: 31039290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
